Applications of Neuroimaging to Disease-Modification Trials in Alzheimer’s Disease

Critical to development of new therapies for Alzheimer’s disease (AD) is the ability to detect clinical or pathological change over time. Clinical outcome measures typically used in therapeutic trials have unfortunately proven to be relatively variable and somewhat insensitive to change in this slow...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Behav Neurol
Main Authors: Fleisher, Adam S., Donohue, Michael, Chen, Kewei, Brewer, James B., Aisen, Paul S., the Alzheimer’s Disease Neuroimaging Initiative
Formato: Artigo
Idioma:Inglês
Publicado em: IOS Press 2009
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5444278/
https://ncbi.nlm.nih.gov/pubmed/19847051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/BEN-2009-0241
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados